RTN4IP1 and mitochondrial disease: A CRISPR/Cas9-based galactose screening identifies key mitochondrial genes involved in OXPHOS and oxidative metabolism, highlighting RTN4IP1 and ECHS1 as uncharacterized regulators with potential implications for mitochondrial diseases.